[Drug distribution to lymph and blood in adjuvant chemotherapy with combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil after surgery in gastric cancer patients].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002277:Carcinoma / Q000097:blood / Q000188:drug therapy*; D003131:Combined Modality Therapy; D006801:Humans; D008196:Lymph / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000097:blood / Q000188:drug therapy*; D005641:Tegafur / Q000008:administration & dosage / Q000493:pharmacokinetics; D014498:Uracil / Q000008:administration & dosage / Q000493:pharmacokinetics
D005641:Tegafur; D014498:Uracil